Carotid artery stenting (CAS) is an endovascular procedure to treat narrowing of the carotid artery, which reduces the risk of transient ischemic attacks (TIAs) or strokes. It involves the placement of a stent in the carotid artery to treat narrowing of the carotid artery and decreases the risk of stroke. A stent is a metal or plastic tube inserted into the lumen of the carotid artery to avoid its narrowing and thereby keeping the passageway open for blood flow. Carotid stenting is the preferred therapy for patients, who do not want to undergo carotid surgery.
Carotid Stenting Systems Market: Drivers and Restraints :The increasing graph of cardiac diseases such as atherosclerosis, coronary artery diseases driven by growing risk factors such as high consumption of cholesterol rich foods, sedentary lifestyles, substance abuse, diabetes, obesity and high blood pressure is the key driver for the growth of the global carotid stenting systems market. According to the Centers for Disease Control and Prevention, coronary artery disease (CAD) is the most common heart disease in the U.S. and is the leading cause of deaths, claiming over 370,000 lives annually.
Technological advancement in stents such as drug eluting stents, use of biodegradable, and bio-absorbable materials for stent construction, improvements in stent design such as bifurcated stents and others are driving the growth of the global carotid stenting systems market owing to greater efficiency and efficacy. Improvements in implantation techniques and development of complementary technologies such as real-time diagnostic imaging such as computed tomography, magnetic resonance imaging and others have resulted in greater confidence and concurrent number of stenting procedures performed. Another advancement is the development of stent coatings to combat stent-based trauma, and restenosis.
The restraining factors of the global carotid stenting systems market are high cost of the procedure, risk of infection and stent failure, thrombosis, restenosis or the re-narrowing of the arteries, and lack of of trained manpower and specialty hospitals. The global carotid stenting systems market also faces competition from balloon angioplasty, coronary angioplasty, and carotid endarterectomy.
Carotid Stenting Systems Market: Overview
The global market for carotid stenting systems is consolidated with a few large players dominating the scene. The market trends include a definite shift in favor of developing regions of Asia Pacific, such as India and China. There is also a strong trend of collaboration between large hospitals and third party payers owing to growing adoption of healthcare insurance.
Carotid Stenting Systems Market: Regional Outlook : The global carotid stenting systems market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to account a large share in the global carotid stenting systems market owing to concentration of key market players, consolidation of healthcare, and large research and development expenditure.
The Asia Pacific excluding Japan carotid stenting systems market is expected to grow at a significant CAGR owing to growing healthcare expenditure. China and India are expected to drive a lion’s share of the market growth owing to growing healthcare infrastructure and expenditure. The expanding number of cases owing to growing risk factors is another driver of the market. Europe carotid stenting systems market is expected to be led by Germany, France and the U.K. The Middle East and Africa carotid stenting systems market is expected to be skewed in favor of the gulf economies of Saudi Arabia, Kuwait, and Qatar. The development of large medical complexes such as the King Fahd Hospital in Riyadh, Saudi Arabia, coupled with the large public healthcare share of which is approximately 75 % of the total healthcare expenditure is expected to drive the market for carotid stenting systems in the MEA.
Request For Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=1025
Carotid Stenting Systems Market: Key Players : Examples of some of the major players operating in the global carotid stenting systems market are Abbott Vascular, Boston Scientific Corporation, Cardinal Health Company, Medtronic, Silk Road Medical, InspireMD, Balton Sp. z o. o., etc. Collaboration between players and strategic business partnerships are the strategies that can yield premium.
The global carotid stenting systems report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.